Overweight, Obesity and Endometrial Cancer Risk: Results from a Systematic Review and Meta-Analysis

2014 ◽  
Vol 29 (1) ◽  
pp. e21-e29 ◽  
Author(s):  
Yuanyuan Zhang ◽  
Huaizhen Liu ◽  
Shengjie Yang ◽  
Jinjun Zhang ◽  
Liwei Qian ◽  
...  

Aim Findings from recent studies suggest that obesity may be associated with an increased risk of endometrial cancer, but several earlier studies were less conclusive. Here we strive to estimate this relationship in a meta-analysis of published data. Methods We searched Pubmed and Embase for studies on body mass index and the risk of endometrial cancer, published from 1989 to 2011. Data were independently extracted and analyzed using random or fixed effects meta-analysis depending on the degree of heterogeneity. Results Seven cohort studies and 11 case-control studies were included in the meta-analysis. Overall, the conditions of excess body weight ([EBW] defined as body mass index [BMI] ≥25 kg/m2), obesity (BMI ≥30 kg/m2) and overweight (25< BMI <30 kg/m2) were associated with an increased risk of endometrial cancer (relative risk [RR] for EBW=1.62, 95% confidence interval [CI], 1.39-1.89; for obesity RR=2.54, 95% CI, 2.11-3.06; for overweight RR=1.32, 95% CI, 1.16-1.50). Subgroup analyses showed that the positive associations were independent of study design, geographic locations, self-reported BMI, alcohol use, smoking habit, history of diabetes, hormone therapy, age at menarche, age at menopause, parity, and age at first full term pregnancy. However, there was no statistically significant association between EBW and endometrial cancer risk for measured BMI (for EBW RR=1.29, 95% CI, 0.66-2.53). Conclusions The findings from this meta-analysis strongly support that the conditions of EBW, overweight, and obesity are all associated with an increased risk of endometrial cancer. Also, the strength of the association increases with increasing BMI.

2010 ◽  
Vol 19 (12) ◽  
pp. 3119-3130 ◽  
Author(s):  
Emma J. Crosbie ◽  
Marcel Zwahlen ◽  
Henry C. Kitchener ◽  
Matthias Egger ◽  
Andrew G. Renehan

2011 ◽  
Vol 117 (4) ◽  
pp. 899-905 ◽  
Author(s):  
Aung Ko Win ◽  
James G. Dowty ◽  
Yoland C. Antill ◽  
Dallas R. English ◽  
John A. Baron ◽  
...  

2016 ◽  
Vol 140 (2) ◽  
pp. 310-315 ◽  
Author(s):  
Julie Aarestrup ◽  
Michael Gamborg ◽  
Kate Tilling ◽  
Lian G. Ulrich ◽  
Thorkild I.A. Sørensen ◽  
...  

2013 ◽  
Vol 23 (3) ◽  
pp. 422-430 ◽  
Author(s):  
Yue Teng ◽  
Caiyun He ◽  
Xiaohang Zuo ◽  
Xu Li

ObjectiveDisordered metabolism of estrogen is believed to play a significant role in endometrial carcinogenesis. Recently, a number of studies have been conducted to identify the role of estrogen-related gene polymorphism in endometrial cancer risk, generating conflicting conclusions. This meta-analysis aimed to assess the association between genetic polymorphisms involving estrogen metabolic enzymes and endometrial cancer risk.MethodsA systematic search of 6 databases was conducted. Fourteen studies on the association of COMT (catechol-O-methyltransferase) Val158Met, CYP1B1 Leu432Val, and CYP1B1 Asn453Ser polymorphisms with endometrial cancer risk were identified, enrolling a total of 4283 cancer cases and 7094 controls. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the relationship.ResultsIn CYP1B1 Leu432Val(rs1056836) analysis, the heterozygous genotype (CG) demonstrated an increased risk for endometrial cancer (Val/Leu vs Leu/Leu: pooled OR, 1.11; 95% CI, 1.01–1.23;P= 0.039;I2= 10.5%; (Val/Val +Val/Leu) vs Leu/Leu: pooled OR, 1.19; 95% CI, 1.03–1.38;P= 0.017;I2= 54.7%). As for CYP1B1 Asn453Ser(rs1800440) polymorphism, a decreased risk was observed in G allele compared with A allele (Ser vs Asn: pooled OR, 0.82; 95% CI, 0.72–0.94;P= 0.005;I2= 0.0%), and heterozygous genotype also showed a decreased risk compared with normal genotype (Ser/Asn vs Asn/Asn: pooled OR, 0.81; 95% CI, 0.69–0.95;P= 0.011;I2= 0.0%). As for COMT Val158Met (rs4680) polymorphism, the heterogeneous genotype showed a decreased risk for endometrial cancer compared with the common homogenous genotype in a fixed-effect model in Asian population (Met/Val vs Val/Val: pooled OR, 0.83; 95% CI, 0.70–0.98;P= 0.033;I2= 29.2%), whereas no positive results are found in other subgroups or models.ConclusionsCOMT Val158Met was seen to show a decreased risk for endometrial cancer in Asian population. CYP1B1 Leu432Val and Asn453Ser polymorphisms demonstrated an increased and decreased risk for endometrial cancer, respectively. Further large and comprehensive studies in various populations with more detailed individual data are needed to confirm our findings.


2002 ◽  
Vol 46 (3-4) ◽  
pp. 147-151 ◽  
Author(s):  
Eleni Petridou ◽  
Maria Belechri ◽  
Nick Dessypris ◽  
Panagiotis Koukoulomatis ◽  
Emmanuel Diakomanolis ◽  
...  

2012 ◽  
Vol 21 (11 Supplement) ◽  
pp. 14-14
Author(s):  
Jennifer Prescott ◽  
Veronica W. Setiawan ◽  
Nicolas Wentzensen ◽  
Fredrick Schumacher ◽  
Herbert Yu ◽  
...  

PLoS ONE ◽  
2015 ◽  
Vol 10 (11) ◽  
pp. e0143256 ◽  
Author(s):  
Jennifer Prescott ◽  
Veronica W. Setiawan ◽  
Nicolas Wentzensen ◽  
Fredrick Schumacher ◽  
Herbert Yu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document